Manama, April 30 (BNA): The National Health Regulatory Authority (NHRA) has developed its service for changes to registered medicines as part of ongoing government efforts to improve service quality and re-engineer procedures. The goal is to improve the customer experience in updating and amending medicine data in accordance with regulatory standards and requirements for the registration of pharmaceutical products.
NHRA develops service for changes to registered medicines Local
In order to guarantee the safety and quality of implementation, the enhanced service has shortened the time needed to finish the process and strengthened the degree of review procedures. This has improved the effectiveness of the regulatory system that oversees pharmaceuticals. This has been made possible by the creation of the service for changes to registered medicines (major/minor), which permits the approval of both major and minor modifications to previously licensed medications following the examination of supporting documentation pertaining to the efficacy, safety, and quality of the product.
Reducing the service completion time from 45 days to 40 working days for big changes and 7 working days for minor adjustments was another aspect of the advancement. The “Adweya” system is used to assess and approve applications that are submitted electronically with supporting documentation and payments. Reducing service levels and the quantity of necessary permissions, as well as standardizing service data across all channels to improve efficiency and transparency, were other improvements.
The development, according to NHRA Chief Executive Dr. Ahmed Mohammed Al Ansari, reflects the authority’s direction toward improving institutional performance by utilizing contemporary technologies to support the effectiveness of pharmaceutical oversight and improve the dependability of procedures in accordance with the best regulatory practices in the health sector.
The development, he continued, demonstrates the NHRA’s desire to enhance its services in a way that saves pharmaceutical companies time and effort, helps to improve procedural efficiency, and supports the safe and effective circulation of pharmaceutical products in accordance with approved regulatory requirements.
Over 1,300 government services have been recorded, translated, and published as part of continuous government efforts to develop and re-engineer government services; approximately 800 services are currently undergoing development and re-engineering across several government sectors.
The National System for Suggestions and Complaints “Tawasul,” investor feedback, secret shopper surveys assessing government services, the introduction of guidance manuals, and service level agreements serve as the foundation for this.
These initiatives enhance the government’s digital transformation process, strengthen beneficiary experiences, improve procedural efficiency, and improve service quality.
